Abstract Title:

Cutaneous vasculitis associated with interferon beta-1b treatment for multiple sclerosis.

Abstract Source:

Clin Neuropharmacol. 2009 Sep-Oct;32(5):301-3. PMID: 19820436

Abstract Author(s):

Jarmila Szilasiová, Zuzana Gdovinová, Jagienka Jautová, Janette Baloghová, Marta Ficová, Peter Bohus

Article Affiliation:

Department of Neurology, Faculty of Medicine, Safarik University, Kosice, Slovakia. jarmila.szilasiova@upjs.sk


We report a 38-year-old woman with relapsing-remitting multiple sclerosis, treated with subcutaneous injections of interferon beta (IFN-beta)-1b every other day. Disseminated cutaneous lesions were observed after 3 injections. These symptoms reappeared after drug readministration. The histopathological examination of the skin specimens confirmed nonspecific cutaneous lymphocytic vasculitis. The patient's outcome was favorable after corticosteroid placement and discontinuing IFN-beta therapy. Isolated lymphocytic cutaneous vasculitis linked to IFN-beta-1b therapy is suspected as a new association.

Study Type : Human: Case Report

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.